Incidence of Pure Red Cell Aplasia Post Allogenic Hematopoietic Stem Cell Transplant in Patients with Major ABO Mismatch in Post Cytoxan Era — a Single Center Analysis

Key Points

• Pure red cell aplasia occurs frequently following allogenic hematopoietic stem cell transplant.
• The analysis indicates a significant incidence rate of pure red cell aplasia in ABO mismatched patients.
• Observational analysis at a single center examined post-transplant outcomes in patients receiving cyclophosphamide.
• Highlights the need for careful monitoring and management strategies in this patient population.